New app from Tempus brings clinical, genomic data to physicians at point of care

Tempus launched a mobile app that provides physicians with relevant clinical and genomic data when providing treatment in an effort to drive personalized oncology care decisions.

Tempus, a precision oncology company, provides physicians with genomic sequencing and molecular analysis services. In the past year, leading hospitals such as Cleveland Clinic, Rochester, Minn.-based Mayo Clinic and University of Chicago Medicine have partnered with Tempus as part of their cancer care programs.

The app, dubbed Tempus Labs, is available on Apple's App Store and the Google Play store for physicians who order one of the company's genomic sequencing services. The app provides access to a patient's report, clinical information, molecular alterations, potential therapies and relevant clinical trial options.

"We live in a mobile society where people have access to incredible amounts of data at their fingertips every day," Eric Lefkofsky, founder and CEO of Tempus, said in a news release. "Our new app is a big step in the right direction to bring some of the advantages of that technology to physicians as they treat patients."

The Becker's Hospital Review website uses cookies to display relevant ads and to enhance your browsing experience. By continuing to use our site, you acknowledge that you have read, that you understand, and that you accept our Cookie Policy and our Privacy Policy.